Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00779558 · ClinicalTrials.gov registry record · NA
Heparin and the Reduction of Thrombosis (HART) Trial
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT00779558: Completed NA study, sponsored by Stanford University.
NCT00779558 is a NA study that has completed, run by Stanford University. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00779558, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
Heparin is frequently used in central venous catheters (CVCs) in post-operative cardiac patients. It remains unclear if a heparin infusion, compared to a normal saline infusion, prevents thrombosis of CVCs after surgery. This study will answer the question: does a low-dose heparin infusion (10 units/kg/h) prevent thrombosis, compared to a normal saline infusion, in patients less than one year of age after cardiac surgery?
Interventions
- DRUG Placebo infusion
- DRUG Heparin sulfate infusion at 10 units/kg/hour
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2005-11 |
| Est. Completion | 2007-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00779558
The ClinicalTrials.gov registry entry for NCT00779558 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo infusion is the first listed.
NCT00779558 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00779558 about?
NCT00779558 is a clinical study titled "Heparin and the Reduction of Thrombosis (HART) Trial". Heparin is frequently used in central venous catheters (CVCs) in post-operative cardiac patients. It remains unclear if a heparin infusion, compared to a normal saline infusion, prevents thrombosis of CVCs after surgery. This study will answer the question: does a low-dose heparin infusion (10 units...
What is the current status of trial NCT00779558?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2005-11. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00779558?
The interventions under investigation include: Placebo infusion (DRUG), Heparin sulfate infusion at 10 units/kg/hour (DRUG).
Who is sponsoring clinical trial NCT00779558?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.